Antitumor activity of Streptococcus thermophilus against fibrosarcoma: role of T-cells. 1991

G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
Bio-Medical Group, Bhabha Atomic Research Centre, Trombay, Bombay, India.

Antitumor activity induced by a heat-killed preparation of S. thermophilus against mouse fibrosarcoma was investigated. The treatment of Swiss mice with S. thermophilus prior to transplantation could not prevent tumors. However, animals cured by treatment with a S. thermophilus preparation failed to take up the tumor when rechallenged with fibrosarcoma. S. thermophilus did not induce antitumor activity in animals immunosuppressed by sublethal whole body gamma-irradiation (4 Gy) or hydrocortisone treatment prior to transplantation. Suppression of activity of macrophages by carrageenan had no effect on antitumor activity of the heat inactivated preparation of S. thermophilus. The intravenous administration of sera from cured animals was ineffective in curing the tumours. Spleen cells from cured animals could effectively transfer the antitumor activity to recipients transplanted with the tumor. This effect was abolished when the T-lymphocyte population in the inoculum was specifically depleted. The results thus suggest the involvement of T-lymphocytes in antitumor activity exhibited by S. thermophilus.

UI MeSH Term Description Entries
D007110 Immunity, Active Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination. Active Immune Response,Active Immune Responses,Active Immunities,Active Immunity,Immune Response, Active,Immune Responses, Active,Immunities, Active,Response, Active Immune,Responses, Active Immune
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008212 Lymphocyte Depletion Immunosuppression by reduction of circulating lymphocytes or by T-cell depletion of bone marrow. The former may be accomplished in vivo by thoracic duct drainage or administration of antilymphocyte serum. The latter is performed ex vivo on bone marrow before its transplantation. Depletion, Lymphocyte
D002351 Carrageenan A water-soluble extractive mixture of sulfated polysaccharides from RED ALGAE. Chief sources are the Irish moss CHONDRUS CRISPUS (Carrageen), and Gigartina stellata. It is used as a stabilizer, for suspending COCOA in chocolate manufacture, and to clarify BEVERAGES. Carrageenin,iota-Carrageenan,kappa-Carrageenan,lambda-Carrageenan,iota Carrageenan,kappa Carrageenan,lambda Carrageenan
D005354 Fibrosarcoma A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed) Fibrosarcomas
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013291 Streptococcus A genus of gram-positive, coccoid bacteria whose organisms occur in pairs or chains. No endospores are produced. Many species exist as commensals or parasites on man or animals with some being highly pathogenic. A few species are saprophytes and occur in the natural environment.

Related Publications

G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
January 1993, Cancer research,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
November 2018, Molecules (Basel, Switzerland),
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
October 1982, Cancer research,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
October 1985, Applied and environmental microbiology,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
January 1980, Journal of cancer research and clinical oncology,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
May 2017, Oncology letters,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
September 2009, Peptides,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
January 2022, PloS one,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
August 1986, Japanese journal of medical science & biology,
G S Kaklij, and S M Kelkar, and M A Shenoy, and K B Sainis
November 2022, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!